These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9463684)

  • 21. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
    Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
    J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis.
    Rainwater-Lovett K; Rodriguez-Barraquer I; Cummings DA; Lessler J
    BMC Infect Dis; 2012 Sep; 12():233. PubMed ID: 23020074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses.
    Roehrig JT; Hombach J; Barrett AD
    Viral Immunol; 2008 Jun; 21(2):123-32. PubMed ID: 18476771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunocytometric assay based on dengue infection via DC-SIGN permits rapid measurement of anti-dengue neutralizing antibodies.
    Martin NC; Pardo J; Simmons M; Tjaden JA; Widjaja S; Marovich MA; Sun W; Porter KR; Burgess TH
    J Virol Methods; 2006 Jun; 134(1-2):74-85. PubMed ID: 16417930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common marmosets (Callithrix jacchus).
    Azami NAM; Moi ML; Ami Y; Suzaki Y; Lim CK; Taniguchi S; Saijo M; Takasaki T; Kurane I
    Virol J; 2018 Mar; 15(1):51. PubMed ID: 29587780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodies.
    Putnak JR; de la Barrera R; Burgess T; Pardo J; Dessy F; Gheysen D; Lobet Y; Green S; Endy TP; Thomas SJ; Eckels KH; Innis BL; Sun W
    Am J Trop Med Hyg; 2008 Jul; 79(1):115-22. PubMed ID: 18606774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralization tests for dengue and Japanese encephalitis viruses by the focus reduction method using peroxidase-anti-peroxidase staining.
    Okuno Y; Igarashi A; Fukai K
    Biken J; 1978 Dec; 21(4):137-47. PubMed ID: 383069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralizing antibody response to Japanese encephalitis inactivated mouse brain vaccine among laboratory personnel.
    Rodrigues FM; Mohan Rao CV; Mandke VB; Pinto BD; Pavri K
    Trans R Soc Trop Med Hyg; 1986; 80(2):301-4. PubMed ID: 3024366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination.
    Vigne C; Dupuy M; Richetin A; Guy B; Jackson N; Bonaparte M; Hu B; Saville M; Chansinghakul D; Noriega F; Plennevaux E
    Hum Vaccin Immunother; 2017 Sep; 13(9):2004-2016. PubMed ID: 28598256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization.
    Morens DM; Halstead SB; Repik PM; Putvatana R; Raybourne N
    J Clin Microbiol; 1985 Aug; 22(2):250-4. PubMed ID: 4031038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies.
    Ferguson M; Johnes S; Li L; Heath A; Barrett A
    Biologicals; 2008 Mar; 36(2):111-6. PubMed ID: 17892945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
    Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis.
    Holzmann H; Kundi M; Stiasny K; Clement J; McKenna P; Kunz C; Heinz FX
    J Med Virol; 1996 Jan; 48(1):102-7. PubMed ID: 8825718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
    Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
    Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rapid fluorescent focus-inhibition test for determining dengue neutralizing antibody and for identifying prototype dengue viruses.
    Thacker WL; Lewis VJ; Baer GM; Sather GE
    Can J Microbiol; 1978 Dec; 24(12):1553-6. PubMed ID: 747816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial.
    Yun KW; Lee HJ; Kang JH; Eun BW; Kim YJ; Kim KH; Kim NH; Hong YJ; Kim DH; Kim HM; Cha SH
    BMC Infect Dis; 2015 Jan; 15():7. PubMed ID: 25567119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological studies with group B arthropod-borne viruses. V. Evaluation of cross-immunity against type 1 dengue fever in human subjects convalescent from subclinical natural Japanese encephalitis virus infection and vaccinated with 17D strain yellow fever vaccine.
    Wisseman CL; Kitaoka M; Tamiya T
    Am J Trop Med Hyg; 1966 Jul; 15(4):588-600. PubMed ID: 4287392
    [No Abstract]   [Full Text] [Related]  

  • 39. Neutralization Assay for Chikungunya Virus Infection: Plaque Reduction Neutralization Test.
    Azami NA; Moi ML; Takasaki T
    Methods Mol Biol; 2016; 1426():273-82. PubMed ID: 27233280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A High-Throughput Yellow Fever Neutralization Assay.
    Rasulova M; Vercruysse T; Paulissen J; Coun C; Suin V; Heyndrickx L; Ma J; Geerts K; Timmermans J; Mishra N; Li LH; Kum DB; Coelmont L; Van Gucht S; Karimzadeh H; Thorn-Seshold J; Rothenfußer S; Ariën KK; Neyts J; Dallmeier K; Thibaut HJ
    Microbiol Spectr; 2022 Jun; 10(3):e0254821. PubMed ID: 35670599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.